Keep up to Date and Stay Informed

Sign up for email alerts to receive company updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

Company Overview

SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas.

Investor Presentation

Investor Presentation

Download

Stock Information

Symbol

Nasdaq: SCYX

Price

Change

Daily Volume

52-week Low/High

Day Low/High

Investor Contact Information

Investor Relations

Argot Partners
Susan Kim
T: 212-600-1902
susan@argotpartners.com

Media Relations

MacDougall Biomedical Communications
George E. MacDougall
T: 781-235-3093
george@macbiocom.com

Transfer Agent

American Stock Transfer & Trust Company, LLC
10150 Mallard Creek Road
Suite 307
Charlotte, NC 28262
T: 800-937-5449